The Board consists of seven members who are appointed by the Governor to three-year terms. There are two public members and five physician members. A member may serve only two consecutive terms. Members sometimes serve beyond the end of their terms before a replacement is appointed. Each member also serves on one or more of the Board's committees.
Candace Lapidus Sloane, M.D.
Chair, Physician Member
Dr. Sloane was appointed to the Board in 2011. She earned BS (Magna Cum Laude) and MD degrees from Tufts University. She interned in Pediatrics at Children's Memorial Hospital in Chicago and served her Pediatric Residency at New York Hospital. She was a Pediatric Fellow and Instructor at Children's Hospital of Philadelphia. She later completed a Residency in Dermatology in the combined Boston University/Tufts University Medical School program, and was Chief Resident in Dermatology her third year. Dr. Sloane was previously board certified in Pediatrics, Dermatology, and Pediatric Dermatology. She served as an Instructor on the faculty of the University of Pennsylvania School of Medicine and Boston University School of Medicine, Director of the Pediatric and Adolescent Dermatology Service and Director of the Community Health Center Initiative in Dermatology at Boston Medical Center; an Assistant Professor of Dermatology and Pediatrics and Director, Fellowship in Primary Care Dermatology at the Boston University School of Medicine; and as an Assistant Professor of Dermatology and Pediatrics at the Alpert School of Medicine at Brown University. At Brown she was head of Pediatric Dermatology at Rhode Island Hospital, served as Dermatology Residency Director, and a Member of the Medical School Admissions Committee. She was a Clinical Assistant Professor of Pediatrics at the Alpert Medical School of Brown University until 2015. Currently she is a Clinical Assistant Professor of Medical Science at the Alpert Medical School of Brown University and a member of the Adjunct Medical Staff at Children’s Hospital Boston. She has lectured widely in the US and Europe, and authored or co-authored many publications in Pediatrics and Dermatology. Her special area of research interest is atopic dermatitis.
Kathleen Sullivan Meyer, Esq.
Public Member, Vice Chair
Ms. Meyer was appointed to the Board in 2012, and is an Attorney at Law. She is a graduate of Newton College of the Sacred Heart, and received her Juris Doctor degree from Suffolk University in 1978. Ms. Meyer practiced at the Boston law firms of Snider, Crowe & Sbrogna and Lubin & Meyer, P.C. She is a member of the Massachusetts Bar Association and Boston Bar Association and is admitted to practice before the United States District Court, First Circuit Court of Appeals. Ms. Meyer has also served on the Board of Corporators of the Massachusetts Society for the Prevention of Cruelty to Children and as Chairman of the Strategic Planning Committee for the Fenn School Board of Trustees in Concord, Massachusetts. Ms. Meyer chairs the Licensing Committee.
George Abraham, M.D.
Dr. George M. Abraham is Professor of Medicine at the University of Massachusetts Medical School, Associate Chief of Medicine at Saint Vincent Hospital, Worcester, Massachusetts and Adjunct Professor at the Massachusetts College of Pharmacy and Health Sciences (MCPHS). He is certified by the American Board of Internal Medicine (ABIM) in Internal Medicine and the subspecialty of Infectious Disease.
Currently, Dr. Abraham serves as the Governor of the MA Chapter of the American College of Physicians (ACP) and as a Trustee of the Massachusetts Medical Society (MMS). He is also one of 7 physicians that make up the Infectious Diseases Board of the ABIM, tasked with governing the certification of physicians in Infectious Disease. Prior to this, he has served on several committees of the MMS, as President of the Worcester District Medical Society, as the Chief Medical Officer of the Central Massachusetts Independent Physician Association and Chair of the Board of Directors of the Health Foundation of Central Massachusetts.
He has received several awards including the AOA Volunteer Faculty Award and the Outstanding Primary Care Educator Award of UMass Medical School, the Leadership Award of the MA chapter of the ACP, the Phi Lambda Sigma honorary Membership, Massachusetts College of Pharmacy and Health Sciences, Worcester, Massachusetts, among others.
Dr. Abraham earned his medical degrees (MBBS and MD) from the Christian Medical College, India, did his residency and chief residency and his infectious disease training at Saint Vincent Hospital/UMass Medical School, and his MPH from the Johns Hopkins Bloomberg School of Public Health.
In addition to his professional career, he volunteers with his church in various outreach projects including a soup kitchen on Saturdays, has led medical mission trips to Mexico and rural (Katrina-devastated) Louisiana, and till recently used to do home visits on his 95-year old patient who was too old to be brought into the office.
Woody Giessmann, LADC-I, CADAC, CIP, CAI
Woody Giessmann, LADC-I, CADAC, CIP, CAI, was appointed to the Board in 2016. Mr. Giessmann is the CEO and founder of Right Turn. Inc. in Watertown, MA. Right Turn, Inc., established in 2003, assists those battling addiction with intensive outpatient, medication assisted treatment and an extended care housing program. Mr. Giessmann is a Licensed Alcohol and Drug Counselor and Certified Interventionist. He became an addiction specialist after his experience as a professional musician. Mr. Giessmann received his BA in Human Service Management from the University of Massachusetts (2003) and a Masters Level Certificate in Community Human Service Management from Suffolk University (2005). He has worked at The Cambridge Health Alliance in Outpatient Addiction Services, and was instrumental in establishing the Cambridge Program of Assertive Community Treatment Team (PACT) for the Department of Mental Health, which serves individuals with severe and persistent mental health issues. In addition, Mr. Giessmann served on the Client Advisory Board for Michael Botticelli from 1996-2001, the MOAR (Massachusetts Organization for Addiction Recovery)Board from 2008 to the present, and was appointed as ethics chairperson for the national Association of Intervention Specialists in 2014.
Michael E. Henry, M.D.
Dr. Michael Henry is a graduate of the University of Massachusetts Medical School in Worcester, Massachusetts. He completed his residency in adult psychiatry at the University of Massachusetts Medical Center. He then assumed the medical directorship of the university’s affiliated unit for mentally ill deaf people. After two years as director, he accepted and completed a fellowship in clinical pharmacology at the Intramural Program of the National Institutes of Mental Health in Bethesda, Maryland.
Dr. Henry subsequently joined Abbott Laboratories as the Associate Medical Director of the team developing Sertindole, a novel antipsychotic medication. Shortly after completion of the new drug application, he moved to McLean Hospital to become the Director of the Electroconvulsive Therapy Service. After 10 years as Director, he switched to a research affiliation at McLean Hospital and joined St. Elizabeth’s Medical Center in Brighton as the Chairman of Psychiatry. Subsequently, he was appointed Vice President of Mental Health for Steward Health.
During his tenure at Steward Health, Dr. Henry received recognition for his outstanding teaching from the Tuft’s University Medical Students and received the annual teaching award from the psychiatry residents in 2010. He also held the position of Director of Residency Training and was the Chairman of the Committee on Graduate Medical Education. He is currently the Director of Somatic Therapy and Medical Director of the Bipolar Clinic and Research Program at the Massachusetts General Hospital.
Dr. Henry’s research interests have been focused on the use of brain imaging techniques to study mood disorders and facilitate drug discovery. He has published over 25 journal articles and book chapters. He has presented this work both nationally and internationally.
Julian N. Robinson, M.D.
Julian N. Robinson trained in medicine at Guy’s Hospital Medical School, University of London. His initial training in Obstetrics and Gynecology was at Guy’s Hospital, London and the Churchill and John Radcliffe Hospitals in Oxford, England. He pursued research in Reproductive Endocrinology as a research fellow at the Nuffield Department of Obstetrics and Gynaecology at Oxford University. After moving to America, he completed a residency in Obstetrics and Gynecology at the Eastern Virginia Medical Center in Norfolk and a fellowship in Maternal Fetal Medicine at the Brigham and Women’s Hospital, Harvard Medical School in Boston. Faculty appointments include Maternal Fetal Medicine attending posts at the New York Presbyterian Hospital and Columbia University in New York and the Brigham and Women’s Hospital and Harvard Medical School, Boston. He was the Medical Director of Maternal Fetal Medicine at Newton Wellesley Hospital in Boston for 9 years. He is currently Chief of Obstetrics at the Brigham and Women’s Hospital and an Associate Professor of Obstetrics, Gynecology, and Reproductive Biology at Harvard Medical School. His professional interests include Quality and Safety and his clinical and research interests include obstetrics, prenatal diagnosis, and twins. He has over 100 academic publications. He is a Diplomate of the Boards of Obstetrics and Gynecology and Maternal Fetal Medicine in America and a Fellow of both the Royal and American Colleges of Obstetrics and Gynecology.
Robin Richman, M.D.
Dr. Richman was appointed to the Board in 2013 and has been reappointed to the Board in 2015. Dr. Richman was chief medical officer and executive vice president for medical affairs at Reliant Medical Group (previously known as the Fallon Clinic) in Worcester, Massachusetts, from 2007 to 2013. In this role, she headed a group medical practice consisting of 240 physicians and 90 advanced practitioners. Before joining Reliant Medical Group, Dr. Richman was Vice-President of Quality and Patient Safety for Atrius Health. Prior to that, Dr. Richman was specialty director of OB/GYN services for Harvard Vanguard Medical Associates (HVMA), leading a large department that included 60 physicians and 20 midwives who delivered care at 17 different practices and 5 Greater Boston-area hospitals. She was also director of CME (continued medical education) for Atrius Health's 600-physician practice and a board member of CRICO/RME, the medical liability organization for the Harvard medical community. Before joining HVMA, Dr. Richman spent two years as the chief medical officer for Tufts Health Care Institute. She also held the chief medical officer position at Women's Health Management Solutions. From 1993 to 2001, Dr. Richman was vice president and medical director of Tufts Health Plan, responsible for NCQA accreditation, member grievances regarding clinical events, all quality measurements and initiatives, and credentialing. She also served as the organizational clinical representative for state and regional legislative initiatives. On a national level, Dr. Richman served on both the Leadership Council and chaired the Women's Health Subcommittee for the American Health Insurance Plans (AHIP). Before turning to more administrative endeavors, Dr. Richman spent 13 years in private OB/GYN practice in association with Newton-Wellesley and Emerson Hospitals in the Boston area. At Emerson, she was the chief of obstetrics and gynecology from 1988 to 1990. Dr. Richman is a graduate of Temple University School of Medicine. She completed her residency at Los Angeles County Women's Hospital and spent a year in a fellowship program at Beth Israel Hospital, Boston, in reproductive endocrinology and infertility.
This information is provided by the Board of Registration in Medicine.